Celgene Corporation (NASDAQ:CELG) received notice of an unsolicited
“mini-tender” offer by TRC Capital Corporation to purchase up to
1,000,000 shares of Celgene’s common stock, approximately 0.13% of
outstanding shares, at $101.75 per share.
for Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation investment picks